Botanical species · safety record

Melaleuca ericifolia

The EFSA Compendium of Botanicals holds 9 constituent measurements for Melaleuca ericifolia. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Melaleuca ericifolia Sm.

9Constituent measurements

0Safety records

6Cited sources

0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
1,8-cineole	Leaves	Essential oil	79.8 Percent	GC-MS	Resolve DOI
Epoxides	Leaves	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	Resolve DOI
Eugenol	Leaves	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	Resolve DOI
Methyleugenol	Leaves	Solvent extraction	96.8 Percent	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	Resolve DOI
1,8-cineole	Leaves	Essential oil	≤ 43.6 Percent	Gaschromatography (GC)	No resolvable identifier
1,8-cineole	Leaves	Essential oil	≥ 13.3 Percent	Gaschromatography (GC)	No resolvable identifier
1,8-cineole	Leaves	Essential oil	≤ 79.5 Percent	—	No resolvable identifier
1,8-cineole	Leaves	Essential oil	≥ 34.5 Percent	—	No resolvable identifier
Methyleugenol	Leaves	Essential oil	96.8 Percent	—	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Abdel Bar, Fatma M., Khanfar, Mohammad A., Elnagar, Ahmed Y., Badria, Farid A., Zaghloul, Ahmed M., Ahmad, Kadria F., Sylvester, Paul W., El Sayed, Khalid A. Design and pharmacophore modeling of biaryl methyl eugenol analogs as breast cancer invasion inhibitors.. Bioorganic & medicinal chemistry, 2010, vol. 18, no. 2, p. 496-507. DOI
Almeida Barbosa, Luiz Claudio., Silva, Cleber Jose., Teixeira, Robson Ricardo., Strozi Alves Meira, Renata Maria., Pinheiro, Antonio Lelis. Chemistry and Biological Activities of Essential Oils from Melaleuca L. Species. Agriculturae Conspectus Scientificus, 2013, vol. 78, no. 1, p. 11-23.
Hussein, S. A. M., Hashim, A. N. M., El-Sharawy, R. T., Seliem, M. A., Linscheid, M., Lindequist, U., Nawwar, M. A. M. Ericifolin: An eugenol 5-O-galloylglucoside and other phenolics from Melaleuca ericifolia . Phytochemistry, 2007, vol. 68, no. 10, p. 1464-1470. DOI
Abdel Bar, Fatma M., Zaghloul, Ahmed M., Bachawal, Sunitha V., Sylvester, Paul W., Ahmad, Kadria F., El Sayed, Khalid A. Antiproliferative triterpenes from Melaleuca ericifolia.. Journal of natural products, 2008, vol. 71, no. 10, p. 1787-90. DOI
Brophy, JJ., Doran, JC. Geographic variation in oil characteristics in Melaleuca ericifolia. Journal of essential oil research, 2004, vol. 16, no. 1, p. 4-8.
Silva, Cleber J., Barbosa, Luiz C. A., Maltha, Ulia R. A., Pinheiro, Antonio L., Ismail, Fyaz M. D. Comparative study of the essential oils of seven Meialeuca (Myrtaceae) species grown in Brazil. FLAVOUR AND FRAGRANCE JOURNAL, 2007, vol. 22, no. 6, p. 474-478. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature